Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41,471 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy.
Liu J, Xu Y, Hu Y, Wang G. Liu J, et al. Among authors: xu y. Metabolism. 2015 Mar;64(3):380-90. doi: 10.1016/j.metabol.2014.11.009. Epub 2014 Nov 28. Metabolism. 2015. PMID: 25516477 Review.
Influence of islet function on typing and prognosis of new-onset diabetes after intensive insulin therapy.
Fan H, Pan Q, Zhang P, Liu J, Xu Y, Yang X. Fan H, et al. Among authors: xu y. Med Sci Monit. 2013 Sep 23;19:787-93. doi: 10.12659/MSM.889099. Med Sci Monit. 2013. PMID: 24056309 Free PMC article.
Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease.
Fan H, Pan Q, Xu Y, Yang X. Fan H, et al. Among authors: xu y. Arq Bras Endocrinol Metabol. 2013 Dec;57(9):702-8. doi: 10.1590/s0004-27302013000900005. Arq Bras Endocrinol Metabol. 2013. PMID: 24402015 Clinical Trial.
Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet.
Pan QR, Ren YL, Zhu JJ, Hu YJ, Zheng JS, Fan H, Xu Y, Wang G, Liu WX. Pan QR, et al. Among authors: xu y. Nutrients. 2014 Jul 14;6(7):2619-31. doi: 10.3390/nu6072619. Nutrients. 2014. PMID: 25025298 Free PMC article.
GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease.
Liu J, Wang G, Jia Y, Xu Y. Liu J, et al. Among authors: xu y. Diabetes Metab Res Rev. 2015 May;31(4):329-35. doi: 10.1002/dmrr.2580. Epub 2014 Sep 14. Diabetes Metab Res Rev. 2015. PMID: 25066109 Review.
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Pan QR, Ren YL, Liu WX, Hu YJ, Zheng JS, Xu Y, Wang G. Pan QR, et al. Among authors: xu y. Nutr Res. 2015 Jul;35(7):576-84. doi: 10.1016/j.nutres.2015.05.006. Epub 2015 May 21. Nutr Res. 2015. PMID: 26055348
Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes.
Chen Z, Miao L, Gao X, Wang G, Xu Y. Chen Z, et al. Among authors: xu y. Int J Clin Exp Med. 2015 Jul 15;8(7):11289-94. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379937 Free PMC article.
PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.
Feng X, Gao X, Jia Y, Zhang H, Xu Y, Wang G. Feng X, et al. Among authors: xu y. Med Sci Monit. 2016 Mar 5;22:743-51. doi: 10.12659/msm.897307. Med Sci Monit. 2016. PMID: 26944934 Free PMC article.
Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.
Fan H, Sun X, Zhang H, Liu J, Zhang P, Xu Y, Pan Q, Wang G. Fan H, et al. Among authors: xu y. Diabetes Technol Ther. 2016 Mar;18(3):120-6. doi: 10.1089/dia.2015.0261. Epub 2016 Mar 7. Diabetes Technol Ther. 2016. PMID: 26950284
Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism.
Wang G, Liu J, Yang N, Hu Y, Zhang H, Miao L, Yao Z, Xu Y. Wang G, et al. Among authors: xu y. Eur J Intern Med. 2016 Jun;31:94-8. doi: 10.1016/j.ejim.2016.03.028. Epub 2016 Apr 13. Eur J Intern Med. 2016. PMID: 27085392
41,471 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page